Table 4.
Linear regression analyses examining the association between eight symptoms (entered as a block) and either CIQ subscale scores or SF-36 Mental Health Index score, controlling for age, sex, and MS subtype.
| Community Integration | Mental Health | |||||||
|---|---|---|---|---|---|---|---|---|
| Home Competency | Social Integration | Productive Activity | SF-36 Mental Health | |||||
|
| ||||||||
| Symptom | Unstandardized beta (95% CI) | β | Unstandardized beta (95% CI) | β | Unstandardized beta (95% CI) | β | Unstandardized beta (95% CI) | β |
|
|
||||||||
| Age | −0.14 (−0.05 – 0.02) | −0.06 | 0.001 (−0.03 – 0.03) | 0.001 | −0.04 (−0.06 − −0.01) | −0.23** | 0.33 (0.08 – 0.59) | 0.19* |
| Sex | −0.78 (−1.5 – 0.03) | −0.133 | −0.37 (−1.07 – 0.33) | −0.07 | 0.23 (−0.28 – 0.73) | 0.06 | 0.73 (−5.52 – 6.97) | 0.02 |
| RR vs. SP | −0.58 (−1.50 – 0.34) | −0.09 | −0.52 (−1.34 – 0.30) | −0.10 | −0.62 (−1.21 − −0.03) | −0.15* | 0.57 (−6.70 – 7.84) | 0.01 |
| RR vs. PP | −0.76 (−1.83 – 0.31) | −0.11 | −0.85 (−1.80 – 0.11) | −0.143 | −0.70 (−1.39 – −0.02) | −0.15* | −3.45 (−11.9 – 5.05) | −0.06 |
| RR vs. PR | −2.34 (−3.58 − −1.11) | −0.27** | −1.97 (−3.06 − −0.87) | −0.26** | −1.10 (−1.80 − −0.23) | −0.17* | −9.90 (−19.7 – 0.13) | −0.15* |
| Fatigue | −0.22 (−0.37 − −0.06) | −0.24** | 0.07 (−0.06 – 0.21) | 0.10 | 0.03 (−0.07 −0.13) | 0.05 | −1.59 (−2.80 − −0.37) | −0.23* |
| Imbalance | −0.04 (−0.19 – 0.11) | −0.05 | 0.11 (−0.02 – 0.24) | 0.16 | −0.03 (−0.12 – 0.07) | −0.05 | 0.54 (−0.63 – 1.71) | 0.09 |
| Weakness | −0.17 (−0.32 − −0.01) | −0.19* | −0.22 (−0.36 − −0.08) | −0.29** | −0.07 (−0.17 – 0.03) | −0.12 | −0.56 (−1.80 −0.68) | −0.08 |
| Numbness | 0.24 (0.12 – 0.37) | 0.29** | −0.03 (−0.14 – 0.08) | −0.04 | 0.06 (−0.03 – 0.14) | 0.10 | 0.23 (−0.76 – 1.22) | 0.04 |
| Pain | 0.03 (−0.11 – 0.17) | 0.04 | −0.09 (−0.22 – 0.03) | −0.12 | −0.07 (−0.16 – 0.01) | −0.123 | −1.35 (−2.45 − −0.26) | −0.20* |
| Memory Loss | 0.01 (−0.14 – 0.15) | 0.01 | −0.18 (−0.31 − −0.05) | −0.24** | 0.10 (−0.19 − −0.01) | −0.17* | −1.14 (−2.28 − −0.01) | −0.17* |
| Vision loss | −0.10 (−0.23 – 0.02) | −0.12 | −0.03 (−0.14 – 0.08) | −0.04 | −0.09 (−0.17 − −0.13) | −0.16* | 0.83 (−0.15 −1.81 | 0.133 |
| Shortness of Breath | 0.05 (−0.12 – 0.22) | 0.04 | 0.07 (−0.09 – 0.22) | 0.07 | −0.07 (−0.174 – 0.04) | −0.09 | −0.67 (−2.01 – 0.66) | −0.08 |
†
p < .10,
*
p < .05,
**
p < .01;
β = standardized beta. N = 175, df = 174 for all tests. RR = relapsing/remitting, SP = secondary progressive, PR = primary progressive, PR = progressive relapsing